News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
JOHNSON CARL J
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/01/2018 |
4
| JOHNSON CARL J (Director) has filed a Form 4 on Prestige Brands Holdings, Inc.|
Txns:
| Granted 3,779 shares
@ $0 |
|
| 08/03/2017 |
4
| JOHNSON CARL J (Director) has filed a Form 4 on Prestige Brands Holdings, Inc.|
Txns:
| Granted 2,564 shares
@ $0 |
|
| 02/16/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/04/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/24/2016 |
4
| JOHNSON CARL J (President & CEO) has filed a Form 4 on Entia Biosciences, Inc.|
Txns:
| Bought options to buy
@ $0.1, valued at
$0
Bought 25,000 warrants
@ $0.125, valued at
$3.1k
|
|
| 08/06/2015 |
4
| JOHNSON CARL J (Director) has filed a Form 4 on Prestige Brands Holdings, Inc.|
Txns:
| Granted 2,075 shares
@ $0
Granted 2,075 shares
@ $0 |
|
| 08/06/2014 |
4
| JOHNSON CARL J (Director) has filed a Form 4 on Prestige Brands Holdings, Inc.|
Txns:
| Granted 1,949 shares
@ $0 |
|
| 07/31/2013 |
4
| JOHNSON CARL J (Director) has filed a Form 4 on Prestige Brands Holdings, Inc.|
Txns:
| Granted 584 shares
@ $0
Granted 1,751 shares
@ $0 |
|
| 06/13/2011 |
4
| JOHNSON CARL J (Director) has filed a Form 4 on SCOLR Pharma, Inc.|
Txns:
| Granted 250,000 options to buy
@ $0.08, valued at
$20k
|
|
| 09/27/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/11/2010 |
4
| JOHNSON CARL J (Director) has filed a Form 4 on SCOLR Pharma, Inc.|
Txns:
| Granted 17,500 options to buy
@ $0.45, valued at
$7.9k
Granted 32,500 options to buy
@ $0.45, valued at
$14.6k
|
|
|
|